Shandong Anhong Pharmaceutical Co., Ltd.
FDA inspection history in Dezhou, China, 2020
- 1
- Form 483
Every document, by year
- Form 483
2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One Form 483, at Dezhou, China.
Cited most
Across all Shandong Anhong Pharmaceutical Co. observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Shandong Anhong Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Dezhou, China
One Form 483 · 2020 · 5 observations
Latest: Form 483, Oct 30, 2020 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-10-30 | 483 Form 483 | Dezhou, China | 5 | $99 |
Investigators on these documents
FEI number 3003877289 · most recent document Oct 30, 2020
About Shandong Anhong Pharmaceutical Co., Ltd.
How many FDA Form 483s has Shandong Anhong Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Shandong Anhong Pharmaceutical Co., Ltd.; the most recent is dated Oct 30, 2020.
When was Shandong Anhong Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shandong Anhong Pharmaceutical Co., Ltd. is a Form 483 dated Oct 30, 2020, for the site in Dezhou, China.
What did FDA cite at Shandong Anhong Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Shandong Anhong Pharmaceutical Co., Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160 (General requirements), 1 time.